Official Title
Imaging Cardiac Phenotype of SARS-Cov-2 (Covid19) Infected Patients
Brief Summary

The effects of severe acute respiratory syndrome SARS-Cov-2 (Covid-19) on the myocardium and their role in the clinical course of infected patients are still unknown. Epidemiological studies report biological myocardial involvement in 10 to 25% of cases. The objective of this study is to cardiac phenotype using comprehensive cardiac imaging tools of patients infected with Covid 19 in order to explore the functional impact of the infection on the myocardium.

Detailed Description

A large population of Covid 19 infected patients of different ages and severity levels will
be explored by transthoracic echocardiography with measurement of myocardial functional
parameters such as ejection fraction, longitudinal strain and relaxation parameters and will
be compared to an uninfected population paired for age and sex.

Patients with biological myocardial involvement will be followed to determine the evolution
of their myocardial functional parameters during the course of the infection.

Completed
Cardiomyopathies

Diagnostic Test: Global Longitudinal Strain

Electrocardiogram with measure of the Global Longitudinal Strain to evaluate myocardiac dysfunction

Eligibility Criteria

Inclusion Criteria:

- Major patients hospitalized for respiratory criteria for SARS-Cov-2 infection
confirmed by RT-PCR

Exclusion Criteria:

- Underage patients. Patients refusing to participate in research. Patients with a
history of heart disease.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

UHToulouse
Toulouse, France

Vincent MINVILLE, PU-PH, Principal Investigator
University Hospital, Toulouse

University Hospital, Toulouse
NCT Number
Keywords
Left ventricular systolic function
left ventricular diastolic function
global longitudinal strain
SARS-CoV-2
Covid-19
MeSH Terms
COVID-19
Cardiomyopathies